Clinical Trial Update: Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen [Phase 2]

View source ↗

Summary

Open-label Phase 2 trial evaluating a steroid-free, calcineurin inhibitor–free, belatacept-based immunosuppressive regimen in kidney transplant recipients; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Kidney Transplantation

Drugs mentioned

• belatacept (belatacept)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Primary Renal Allograft Candidate, Kidney Transplantation | Phase 2 | Status: TERMINATED | Results posted: 2017-08-07